↓ Skip to main content

Cochrane Database of Systematic Reviews

Rituximab, ofatumumab and other monoclonal anti‐CD20 antibodies for chronic lymphocytic leukaemia

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
189 Mendeley
Title
Rituximab, ofatumumab and other monoclonal anti‐CD20 antibodies for chronic lymphocytic leukaemia
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd008079.pub2
Pubmed ID
Authors

Kathrin Bauer, Michaela Rancea, Verena Roloff, Thomas Elter, Michael Hallek, Andreas Engert, Nicole Skoetz

Abstract

Chronic lymphocytic leukaemia (CLL) accounts for 25% of all leukaemias and is the most common lymphoid malignancy in western countries. Standard treatments include mono- or polychemotherapies, usually combined with monoclonal antibodies such as rituximab or alemtuzumab. However, the impact of these agents remains unclear, as there are hints for increased risk of severe infections.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 189 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
Colombia 1 <1%
France 1 <1%
Brazil 1 <1%
Russia 1 <1%
Croatia 1 <1%
Unknown 182 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 12%
Researcher 22 12%
Student > Bachelor 22 12%
Student > Ph. D. Student 21 11%
Other 15 8%
Other 34 18%
Unknown 52 28%
Readers by discipline Count As %
Medicine and Dentistry 81 43%
Agricultural and Biological Sciences 11 6%
Nursing and Health Professions 9 5%
Biochemistry, Genetics and Molecular Biology 8 4%
Psychology 6 3%
Other 19 10%
Unknown 55 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2013.
All research outputs
#7,869,634
of 25,850,671 outputs
Outputs from Cochrane database of systematic reviews
#9,139
of 13,147 outputs
Outputs of similar age
#56,899
of 193,597 outputs
Outputs of similar age from Cochrane database of systematic reviews
#172
of 243 outputs
Altmetric has tracked 25,850,671 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 13,147 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.5. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 243 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.